ESR1 and breast cancer: We showed that OSU-ERb-12, like the control compound LY500307, exerted significant cytotoxicity toward MCF7 and T47D ERα+ breast cancer cell lines with IC50 values that were lower compared to immortal mammary epithelial cells (MCF10A).